| Tissue Source Sites Contributing to TCGA

A number of institutions contribute samples to The Cancer Genome Atlas (TCGA) program. These institutes are called Tissue Source Sites. The clinicians who collect these specimens are critical members of the TCGA Research Network. Their contribution of tissue and clinical and biomedical expertise are invaluable.

As of August 2009, the following institutions have contributed samples to TCGA:

Glioblastoma multiforme biospecimens:

• Case Western Reserve University, Cleveland, Ohio
  Principal Investigator: Andrew Sloan, M.D.
• Cedars-Sinai Medical Center, Los Angeles, Calif.
  Principal Investigator: Keith Black, M.D.
• Duke University, Durham, N.C.
  Principal Investigator: Darryl Bigner, M.D., Ph.D.
• Emory University School of Medicine, Atlanta, Ga.
  Principal Investigator: Erwin Van Meir, Ph.D.
• Fondanzione IRCCS Neurological Institute, Milan, Italy
  Principal Investigator: Gaetano Finocciaro, M.D.
• Henry Ford Hospital System, Detroit, Mich.
  Principal Investigator: Tom Mikkelson, M.D.
• Mayo Clinic, Rochester, Minn.
  Principal Investigator: Brian O’Neill, M.D.
• MD Anderson Cancer Center, Houston, Texas
  Principal Investigator: Kenneth Aldape, M.D.
• Roswell Park Cancer Institute, Buffalo, N.Y.
  Principal Investigator: Carl Morrison, M.D., D.V.M.
• St. Joseph’s Hospital and Medical Center, Phoenix, Ariz.
  Principal Investigator: Joan Shapiro, M.D., Ph.D.
• Toronto Western Hospital, Ontario, Canada
  Principal Investigator: Abhijit Guha, M.D.
• University of California at San Francisco Medical Center, San Francisco, Calif.
  Principal Investigator: Mitchel Berger, M.D.
• University of Florida, Gainesville, Fla.
  Principal Investigator: William Friedman, M.D.

Squamous cell carcinoma of lung biospecimens:

• Fox Chase Cancer Center, Philadelphia, Pa.
  Principal Investigator: Andrew Godwin, Ph.D.
• Mayo Clinic, Rochester, Minn.
  Principal Investigator: Dennis Wigle, M.D., Ph.D.
• MD Anderson Cancer Center, Houston, Texas
  Principal Investigator: Ignatious Wistuba, M.D.

Serous cystadenocarcinoma of the ovary biospecimens:

• Brigham and Woman’s Hospital, Boston, Mass.
  Principal Investigator: Daniel Cramer, M.D., Sc.D
• British Columbia Cancer Agency, Vancouver, British Columbia, Canada
  Principal Investigator: David Huntsman, M.D.
• Cedars-Sinai Medical Center, Los Angeles, Calif.
  Principal Investigator: Beth Karian, M.D.
• Duke University, Durham, N.C.
  Principal Investigator: Andrew Berchuck, M.D.
• Fox Chase Cancer Center, Philadelphia, Pa.
  Principal Investigator: Andrew Godwin, Ph.D.
• Gynecology Oncology Group, Crofton, Md.
  Principal Investigator: Michael Birrer, M.D., Ph.D.
• Imperial College of Science technology and Medicine, London, United Kingdom
  Principal Investigator: Hani Gabra, M.D., Ph.D.
• Mayo Clinic, Rochester, Minn.
  Principal Investigator: Jeremy Chien, Ph.D.
• MD Anderson Cancer Center, Houston, Texas
  Principal Investigator: Anil Sood, M.D.
• Memorial Sloan-Kettering Cancer Center, New York, N.Y.
  Principal Investigator: Douglas Levine, M.D.
• University of California at San Francisco Medical Center, San Francisco, Calif.
  Principal Investigator: Karen McCune, M.D.
• University of Pittsburgh, Pittsburgh, Pa.
  Principal Investigator: Rajiv Dhir, M.D.
• Washington University, St. Louis, Mo.
  Principal Investigator: Janet Rader, M.D.

For more information, read about The Cancer Genome Atlas Biospecimen Selection Process .